[1]
Z. Chen, “CT-guided 125I brachytherapy for hepatocellular carcinoma in high-risk locations after transarterial chemoembolization combined with microwave ablation: a propensity score-matched study: CT-guided 125I brachytherapy for HCC in high-risk locations after TACE combined with MWA: a propensity score-matched study”, Radiol Oncol, vol. 57, no. 1, pp. 127–139, Mar. 2023.